Embolosclerotherapy Versus Deep Dorsal Vein Revascularization in Venogenic Erectile Dysfunction
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age40-80
SponsorMansoura University Hospital
About this trial
Venous leakage is one of the causes of erectile dysfunction and can be managed using different treatment modalities, including surgical ligation and percutaneous embolization. This randomized clinical trial aims to evaluate and compare the efficacy, durability, safety, side effects, and complications of two treatment procedures-embolosclerotherapy of the periprostatic plexus and deep dorsal vein revascularization-in the management of erectile dysfunction caused by venous leak.
Eligibility criteria
Qualifiers
Cases with ED reporting difficulty in attaining or maintaining erection for at least 6 months.
All participants were sexually active, in a stable and heterosexual partnership, living with their sexual partner for at least the past one year, and have only one sexual partner.
The frequency of trying sexual intercourse was ≥1/week.
Unsatisfactory response to PDE5i medication.
Disqualifiers
Refusal to participate.
Major psychological or psychiatric disorders.
Non-vascular causes of ED including penile anatomic defects, any related neurological etiology or spinal cord injury, hypogonadism and hormonal disturbances.
History of previous venous surgery, suspected or proven deep venous thrombosis, history of Deep Vein Thrombosis.
Trial design
Treatments tested in this trial
- Endovascular embolosclerotherapy
- Revacularization of deep dorsal vein
Treatment groups
60 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov